Investors

Our Journey

May 2015 

Company founded in Malaysia‚Äč

July 2015

Successfully awarded seed grant of USD150,000 by Malaysian government agency, Platcom Ventures

August 2015

Selected by Malaysia Global Innovation & Creativity Centre (MaGIC) for e@Stanford USA Program Batch 2015

November 2018

Launching of biosensor platform for molecular diagnostics

May 2019

Launching of in silico platform for design and validation of oligo-based synthetic antibodies (aptamers)

July 2019

Participated in NextRise 2019 Korea for pitching to regional investors

For more detailed information, please email contact@biogenestech.com